Korro Bio
KRRO
91 hedge funds and large institutions have $198M invested in Korro Bio in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 42 increasing their positions, 26 reducing their positions, and 35 closing their positions.
62% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 26
18% more call options, than puts
Call options by funds: $4.87M | Put options by funds: $4.12M
5% more capital invested
Capital invested by funds: $189M → $198M (+$8.64M)
0.03% less ownership
Funds ownership: 1.17% → 1.14% (-0.03%)
21% less funds holding
Funds holding: 115 → 91 (-24)
66% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 35
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$13.9M |
| 2 |
Morgan Stanley
New York
|
+$6.84M |
| 3 |
BlackRock
New York
|
+$4.9M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$4.75M |
| 5 |
SDIC
South Dakota Investment Council
Sioux Falls,
South Dakota
|
+$3.89M |
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$18.5M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$11.4M |
| 3 |
State Street
Boston,
Massachusetts
|
-$7.58M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$4.51M |
| 5 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
-$2.5M |
KRRO Hedge Fund Activity: Q2 2021 in Review
91 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q2 2021, worth a combined $198M — up 4.6% from $189M a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of KRRO and 12 opened new positions — a net loss of 23 holders — while 26 trimmed existing stakes and 42 added.
The largest buyer was JP Morgan Chase, adding an estimated $13.9M. The largest seller was Perceptive Advisors, cutting an estimated $18.5M.
- 91 institutional investors held Korro Bio (KRRO) as of Q2 2021, down from 115 in Q1 2021.
- Funds reported $198M of Korro Bio stock for Q2 2021, up 4.6% quarter-over-quarter.
- 12 funds opened new Korro Bio positions in Q2 2021 and 35 closed out, a net change of -23 holders.
- The largest Korro Bio buyer in Q2 2021 was JP Morgan Chase, an estimated $13.9M added.
- The largest Korro Bio seller in Q2 2021 was Perceptive Advisors, an estimated $18.5M sold.
Based on aggregated 13F filings for Q2 2021.